Jump to content

Medway School of Pharmacy

Medical examination in a doctor's room

Medicines Optimisation - PCert, PDip, MSc

2022

The Medway School of Pharmacy’s innovative postgraduate distance-learning programme in Medicines Optimisation equips you with the skills and knowledge to contribute effectively to medicines management services and to individual drug therapy decisions.

2022

Overview

Learn how Medicines Optimisation is used to determine how medicines are used by patients and the NHS. Effective medicines optimisation places the patient as the primary focus of interventions by healthcare professionals and is a key driver for NHS modernisation in the UK. Become proficient in planning clinical and cost-effective medicines use in the context of the holistic consideration of patient needs.

One pathway to the MSc includes the chance for you to qualify as an independent/supplementary prescriber. Have a look at the Independent / Supplementary Prescribing programme for more details. 


About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

Fees

For fee information, please email pgtpharmadmin@kent.ac.uk

National ratings

In the Research Excellence Framework (REF) 2014, research by the School of Pharmacy was ranked 8th in the UK for research intensity.

An impressive 100% of our research-active staff submitted to the REF and 93% of our research was judged to be of international quality, with 81% of this judged world-leading or internationally excellent. The School’s environment was judged to be conducive to supporting the development of world-leading research.

Project Titles Supervisors
Circadian Rhythms and Aging Dr Gurprit Lall, Dr Aiste Steponenaite
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens Dr Nigel Temperton, Dr Simon Scott , Prof Jonathan Heeney (University of Cambridge)
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics Dr Simon Scott , Dr Nigel Temperton, Dr Matthew Reeves (UCL)
Formulation of layered silicate-polymer composite particles for the potential oral delivery of biologics Dr Vivek Trivedi, Dr Vadim Sumbayev
The Creation of Anti-Viral Plastic Nanobodies for Diagnostics and Therapeutics via Molecular Imprinting of Synthetic Polymers Dr Andrew J Hall, Dr Nigel Temperton
Deciphering the landscape of nucleoporin and lamin function in nucleocytoplasmic communication, nuclear scaffolding and transcriptional control in disease prevention Dr Fani Papagiannouli, Dr Gurprit Lall
Design, Synthesis and Biological Evaluation of Tumour Targeting Analogues of Combretastatin A4 Dr M A Casely-Hayford, Dr N Lavignac, Dr V Sumbayev
Cross-modal sensory integration for motor decision making. Dr Stella Koutsikou, Dr Tobias von der Haar
Development of lipid-polymer hybrid nanoparticles via microfluidics, for the intracellular delivery of nucleic acid therapeutics Dr Nathalie Lavignac, Dr Vladimir Gubala
Cross-talks of immune checkpoint pathways determine the abilities of human malignant tumours to suppress cytotoxic attacks and escape immune surveillance Dr Vadim V Sumbayev